Enhancing regeneration and functional recovery after acute spinal cord injury

Imprint

Imprint & Legal notice

The NISCI public website is provided by the consortium partner 

tp21 GmbH  - Luisenstrasse 14  - D-10117 Berlin
Tel:  +49 (0)30 530 45 95 5
E-mail: info@tp21.com
Web: www.tp21.com

Vertretungsberechtigte Geschaeftsfuehrerin (CEO): Dr. Petra Zalud 
Registergericht (registered at): Amtsgericht Charlottenburg Berlin
Registernummer: HRB 156791 B
Umsatzsteueridentifikationsnummer gemaess § 27a Umsatzsteuergesetz (VAT-number): DE 229 548 135

Notice of liability
Despite careful control, we cannot assume any liability for the content of the linked pages. The owners of the respective linked-to pages are solely liable for the contents.

Pictures & Figures©
Photo cover page: Stefan Weiss, partners in GmbH, Zürich
Photo 'Care': Universitätsklinik Balgrist, Zürich, I. Krüsi, 2016
Scheme 'Stages of Clinical Trials': Universitätsklinik Balgrist, Zürich, A. Prusse, 2016
Image 'Lumbalpunktion': authorised by MSD
Photo 'MRI': Universitätsklinik Balgrist, Zürich, Klinik allgemein, MR Magnetdom Verio, 10.09.2009, Sachaufnahme
Image ´Lab'  Fotolia_135807945
Image 'Nogo-A-Antibody': Buchli A., Schwab M., BioFokus 73, September 2016
Image 'Spinal Cord Damage': authorised by Aaron G. Filler, MD, PhD, FRCS, Medical Director, Institute for Nerve Medicine, Santa Monica, California

 

This project has received funding from the European Union's Horizon 2020 research and innovation programme under the grant agreement No 681094,and is supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137.